Skip to contentSkip to navigation

Specialist Advice — 9 minutes

What is insomnia?

February 20, 2026

Sleep care team
Sleep care team
info@biron.com

Insomnia is a sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep, despite a conducive sleep environment and conditions. It is accompanied by daytime functioning disturbances such as fatigue, cognitive impairment, mood changes, or alertness. To be considered a disorder, insomnia must occur at least three times a week and persist for a month or more. [1]

It is one of the most common sleep disorders. According to a 2024 study, 16.3% of Canadian adults suffer from insomnia, which is approximately 6.5 million people. [2] This disorder can affect anyone, even children, but it is more prevalent among the elderly, women, disadvantaged individuals, people in poor health, and those with atypical work schedules.

Causes

Insomnia can be linked to a stressful event (problems at work, bereavement, divorce, etc.). This is referred to as temporary or acute insomnia, although it can last for several weeks. It usually resolves itself once the triggering factor disappears. Insomnia is often caused or aggravated by poor sleep habits, such as consuming coffee or tobacco in the hours before bedtime, excessive alcohol consumption, engaging in intense activity late at night, irregular schedules, or a disruptive environment (noise, light, temperature, etc.).

It can accompany physical problems, such as heart and lung disease, musculoskeletal disorders and chronic pain, or psychological disorders, such as depression and anxiety. It can also be associated with other sleep disorders, including obstructive sleep apnea, which is very often diagnosed in people who complain of insomnia or non-restorative sleep. This medical condition is called comorbid insomnia and sleep apnea, better known by the acronym COMISA.

Symptoms

In addition to having difficulty falling asleep, waking up frequently or experiencing prolonged periods of wakefulness during the night, waking up early in the morning and being unable to fall back asleep, a person suffering from insomnia will not feel rested in the morning. They may also experience various symptoms during the day, such as irritability, excessive fatigue (physical and mental), episodes of drowsiness, decreased motivation, headaches, digestive problems, and difficulty concentrating or paying attention. In the long term, lack of sleep can disrupt daily activities, reduce quality of life, aggravate the symptoms of other illnesses and cause accidents. Insomnia is also associated with an increased risk of suicide, especially when it coexists with psychiatric disorders such as major depression. This link has been observed in adults as well as children and adolescents. [3]

Diagnosis

If insomnia symptoms have only lasted a few days, adopting better sleep hygiene can be beneficial. However, if difficulty sleeping occurs at least three nights a week for more than three months, insomnia is chronic and requires consultation.

The diagnosis of insomnia is usually based on a thorough clinical assessment, including a detailed history of the person's sleep complaints. This assessment also aims to identify any psychiatric comorbidities, as well as medical or pharmacological factors that may alter sleep quality. To fully understand the problem, it may be helpful to keep a sleep diary for one to three weeks, noting when and under what conditions insomnia occurs, the severity of episodes, and their impact on daily life.

Polysomnography (PSG) is not routinely recommended for the diagnosis of chronic insomnia. Its use is limited to cases where another sleep disorder is suspected.

Treatment for insomnia

Today, there are effective, non-pharmaceutical treatments that are scientifically proven to improve sleep in the long term. At Biron, all insomnia treatment begins with a clinical sleep assessment, followed by an intervention tailored to the individual's situation.

CBT-I: an effective and accessible first step

Brief behavioural treatment for insomnia (B-CTI) is often the first line of treatment. This approach, validated by scientific research, targets behaviours that contribute to sleep difficulties. Generally offered in three or four sessions, B-CTI is based on recognised behavioural strategies, including: * restricting time spent in bed to increase sleep pressure. * stimulus control, to reassociate the bed and bedroom with sleep * sleep education, to better understand sleep mechanisms and avoid certain compensatory behaviours that, in the long term, aggravate insomnia.

Several studies show that TCB-I reduces the time it takes to fall asleep and night-time awakenings and improves sleep quality. In the short term, its results are comparable to those of cognitive behavioural therapy for insomnia (CBT-I), while requiring less time and resources. [4]

At Biron, CBT-I is provided by certified sleep health professionals, such as nurses and respiratory therapists, who are specifically trained in this approach. It is an accessible, structured and effective option for most people suffering from insomnia.

CBT-I: the gold standard treatment for complex cases

CBT-I remains the gold standard treatment for complex or persistent chronic insomnia. It combines behavioural and cognitive strategies to work in depth on the thoughts, beliefs and concerns that interfere with sleep.

CBT-I is generally offered in 5 to 12 sessions, depending on the programme and individual needs, and is provided by psychologists, psychotherapists or social workers.

A structured approach focused on your needs

In most cases, CBT-I is effective. However, when sleep difficulties persist or complex cognitive issues are identified during follow-up, a referral to CBT-I may be recommended.

At Biron, your journey begins with a comprehensive assessment and personalised support from our team of sleep care specialists. It consists of three stages:

  1. A thorough assessment of your situation;
  2. An initial intervention based on TCB-I;
  3. A referral to CBT-I if necessary.

Medication

If insomnia persists, medication may be used. However, according to Charles Morin, professor at Laval University and world-renowned expert on insomnia, medication does not eliminate the cause of insomnia and should be considered an occasional lifeline. [5]

  • There are seven main categories of sleeping pills (hypnotics) that can be prescribed to help patients get some rest, but only for a short period (two to four weeks), as they carry a risk of dependence, and some lose their effectiveness after a few weeks.
  • Antihistamine hypnotics include most over-the-counter medications. These are not sleeping pills; they are medications commonly used to treat allergies that can cause drowsiness. However, their effectiveness in treating insomnia has not been clearly demonstrated [6], and their side effects are similar to those of sleeping pills.
  • Melatonin is a hormone secreted by the brain that helps maintain the sleep-wake cycle. It also exists in synthetic form in over a hundred products approved as natural health products in Canada. However, it is important to note that in North America, the actual melatonin content of natural supplements can vary considerably—from -83% to +478% of the dose indicated on the label—which can affect their efficacy and safety. [7] Although it promotes sleep and may be beneficial for certain sleep disorders, its effectiveness in treating insomnia appears to be limited. [8]

For professional support, we’re here.

We offer services that can assist your doctor in diagnosing sleep disorders and determining the appropriate treatment.

Do you have a medical prescription for one of these tests? Book an appointment online or contact Biron Health Group’s customer service at 1 833 590-2712.

Sources8
  1. Roth, T. Insomnia: Definition, Prevalence, Etiology, and Consequences. J Clin Sleep Med 3 (Suppl 5), S7–S10 (2007). https://doi.org/10.5664/jcsm.26929
  2. Sleep Med. (2024). Prevalence of insomnia and use of sleep aids among adults in Canada. https://pubmed.ncbi.nlm.nih.gov/39369578
  3. McCall WV, Black CG. The link between suicide and insomnia: theoretical mechanisms. Curr Psychiatry Rep. 2013 Sep;15(9):389. https://pmc.ncbi.nlm.nih.gov/articles/PMC3791319/.
  4. American Academy of Sleep Medicine. (2020). Behavioral and psychological treatments for chronic insomnia disorder in adults. https://jcsm.aasm.org/doi/10.5664/jcsm.8988
  5. Proulx, Marie-Hélène. « À la recherche du sommeil perdu », L’actualité, 4 novembre 2020, https://lactualite.com/societe/a-la-recherche-du-sommeil-perdu/
  6. Culpepper Larry et Mark A. Wingertzahn. « Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety », The Primary Care Companion for CNS Disorders, vol. 17, no 6, 31 déc. 2015, DOI: 10.4088/PCC.15r01798
  7. Erland, L., Saxena, P. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med 13, 275–281 (2017). https://link.springer.com/article/10.5664/jcsm.6462#citeas
  8. Costello, Rebecca, Cynthia Lentino, Courtney Boyd, Meghan O'Connell, Cindy Crawford, Meredith Sprenel et Patricia Deuster. « The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature », Nutrition Journal, vol. 13, no 1, p. 106, 2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273450/
Sleep care team
Sleep care team
info@biron.com